21 Sep 2021
A new treatment for ovarian cancer has shown great effectiveness in early trials, where it significantly shrunk tumours in 46% of patients with a resistant form of the disease, according to data presented at the European Society for Medical Oncology Congress.
Migraines and menopause symptoms linked to cardiovascular disease risk
19 Apr 2024
Risk of postpartum depression associated with stress during adolescence
19 Apr 2024
Surgery for hypoparathyroidism sees reduced facture rates
19 Apr 2024
Patients with type 2 diabetes taking antidepressants have a higher mortality risk
19 Apr 2024
Endocrine-disrupting chemical levels found at alarming levels in Australia
11 Apr 2024